TIL
TIL
NASDAQ · Biotechnology

Instil Bio Inc

$8.18
-0.06 (-0.73%)
As of Apr 1, 3:35 PM ET ·
Financial Highlights (FY 2025)
Revenue
12.19M
Net Income
876.0K
Gross Margin
40.2%
Profit Margin
7.2%
Rev Growth
+7.7%
D/E Ratio
1.27
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 40.2% 40.2% 40.2%
Operating Margin 11.0% 10.9% 10.6%
Profit Margin 7.2% 7.9% 7.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.19M 11.47M 10.10M
Gross Profit 4.89M 4.60M 4.06M
Operating Income 1.34M 1.25M 1.07M
Net Income 876.0K 905.7K 740.1K
Gross Margin 40.2% 40.2% 40.2%
Operating Margin 11.0% 10.9% 10.6%
Profit Margin 7.2% 7.9% 7.3%
Rev Growth +7.7% +14.6% +19.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 22.74M 26.22M 27.61M
Total Equity 17.95M 19.41M 20.13M
D/E Ratio 1.27 1.35 1.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.90M 1.88M 1.67M
Free Cash Flow 486.5K 519.3K 559.1K